₹1,505.30-20.70 (-1.36%)
04:01 PM, 30-Dec-2025₹1,500.20-25.60 (-1.68%)
03:49 PM, 30-Dec-2025BSE : 540596
NSE : ERIS
Sector : Health care
ISIN Code : INE406M01024
Last Updated: 30-Dec-2025 | 04:01 PM IST
| Market Cap (₹ Cr) | 20,502 |
Traded Value (₹ Cr) | 3.42 |
Volume (Shares) | 22,702 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,909.55 |
52-Week High Date | 12-Jun-2025 |
52-Week Low (₹) | 1,130.05 |
52-Week Low Date | 28-Jan-2025 |
All Time High (₹) | 1,909.55 |
All Time High Date | 12-Jun-2025 |
All Time Low (₹) | 341.05 |
All Time Low Date | 30-Mar-2020 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 20,433 |
| EPS - TTM (₹) [C] | 32.96 |
| P/E Ratio (X) [C] | 45.52 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 735.00 |
| Latest Dividend Date | 13-Feb-2025 |
| Dividend Yield (%) | 0.49 |
| Book Value Share (₹) [C] | 226.93 |
| P/B Ratio (₹) [C] | 6.61 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Franklin India Retirement Fund (G) | 2.45 | 15,441 | 0.47 |
| Franklin India Retirement Fund (IDCW) | 2.45 | 15,441 | 0.47 |
| Franklin India Retirement Fund - Direct (G) | 2.45 | 15,441 | 0.47 |
| Franklin India Retirement Fund - Direct (IDCW) | 2.45 | 15,441 | 0.47 |
| SBI Ultra Short Duration Fund - Reg (G) | 151.32 | 15,000 | 0.97 |
| SBI Ultra Short Duration Fund - Reg (IDCW-W) | 151.32 | 15,000 | 0.97 |
| SBI Ultra Short Duration Fund - Reg (IDCW-D) | 151.32 | 15,000 | 0.97 |
| SBI Ultra Short Duration Fund - Dir (IDCW-D) | 151.32 | 15,000 | 0.97 |
| SBI Ultra Short Duration Fund - Dir (IDCW-W) | 151.32 | 15,000 | 0.97 |
| SBI Ultra Short Duration Fund - Dir (G) | 151.32 | 15,000 | 0.97 |
Load more
| Today's Low/High (₹) | 1,469.10 1,532.70 |
| Week Low/High (₹) | 1,469.10 1,576.00 |
| Month Low/High (₹) | 1,469.10 1,740.00 |
| Year Low/High (₹) | 1,097.20 1,910.00 |
| All time Low/High (₹) | 341.05 1,910.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -3.25% | -3.34% | -0.99% | -0.91% |
| 1 Month | -5.96% | -5.97% | -1.20% | -1.01% |
| 3 Month | -5.56% | -5.40% | 5.49% | 5.39% |
| 6 Month | -10.95% | -10.90% | 1.28% | 1.65% |
| 1 Year | 8.75% | 8.35% | 8.21% | 9.70% |
| 3 Year | 132.41% | 131.78% | 39.17% | 43.27% |
Chairman / Executive Director / M D / Promoter : Amit Indubhushan Bakshi
WTD & Executive Director : Kaushal Kamlesh Shah
WTD & Executive Director : Inderjeet Singh Negi
Executive Director / WTD / Chief Operating Officer : Krishnakumar Vaidyanathan
Independent Non Exe. Director : Prashant Gupta
Independent Non Exe. Director : Rajeev Narotam Dalal
Independent Non Exe. Director : Kalpana Unadkat
Independent Non Exe. Director : Sujesh Vasudevan
Company Sec. & Compli. Officer : Milind Talegaonkar
Registered Office: 8th Floor Commerce House -IV, Prahladnagar 100 FT Road,Ahmedabad,Gujarat-380015 Ph: 91-79-30451000
1. What's the ERIS Lifesciences Ltd share price today?
ERIS Lifesciences Ltd share price was Rs 1,505.30 at 04:01 PM IST on 30th Dec 2025. ERIS Lifesciences Ltd share price was down by 1.36% from the previous closing price of Rs 1,526.00. ERIS Lifesciences Ltd share price trend:
2. How can I quickly analyse the performance of the ERIS Lifesciences Ltd stock?
The performance of the ERIS Lifesciences Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of ERIS Lifesciences Ltd?
ERIS Lifesciences Ltd has a market capitalisation of Rs 20,502 crore.
4. What is ERIS Lifesciences Ltd's 52-week high/low share price?
The ERIS Lifesciences Ltd’s 52-week high share price is Rs 1,909.55 and 52-week low share price is Rs 1,130.05.
5. Is the ERIS Lifesciences Ltd profitable?
On a consolidated basis, ERIS Lifesciences Ltd reported a profit of Rs 134.47 crore on a total income of Rs 795.50 crore for the quarter ended 2025.
6. Which are ERIS Lifesciences Ltd’s peers in the Health care sector?
ERIS Lifesciences Ltd’s top 5 peers in the Health care sector are Pfizer, Wockhardt, Astrazeneca Phar, ERIS Lifescience, Cohance Life, OneSource Speci., Sai Life.
7. Who owns how much in ERIS Lifesciences Ltd?
Key changes to the ERIS Lifesciences Ltd shareholding are as follows: